Skip to main
SHC

Sotera Health (SHC) Stock Forecast & Price Target

Sotera Health (SHC) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 29%
Buy 57%
Hold 14%
Sell 0%
Strong Sell 0%

Bulls say

Sotera Health is a promising investment opportunity as the company has shown consistent growth in revenue, beating expectations in all three segments. The recent legal settlements and their balanced legal strategy show a promising outlook for continued de-risking and potential increase in valuation for the stock. With a new CEO in place and a strategic planning process underway, growth acceleration is expected both organically and inorganically.

Bears say

Sotera Health is facing a new CEO transition, with Alton Shader taking over from outgoing CEO Michael Petras. The company delivered strong growth in its Sterigenics segment, driven by pricing and despite weather-related headwinds. Additionally, the company has seen positive outcomes in ongoing litigation cases, which should help to further mitigate risks. However, looming questions regarding commercial execution and litigation processes may continue to weigh on investors' minds.

Sotera Health (SHC) has been analyzed by 7 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 57% recommend Buy, 14% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Sotera Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Sotera Health (SHC) Forecast

Analysts have given Sotera Health (SHC) a Buy based on their latest research and market trends.

According to 7 analysts, Sotera Health (SHC) has a Buy consensus rating as of Aug 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $21.86, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $21.86, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Sotera Health (SHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.